PolyU develops novel antibody targeting fat cell protein, offering new approach to treating metabolism-related liver cancer (IMAGE)
Caption
Prof. Terence Lee and his research team discovered that FABP4 levels are significantly elevated in the serum of patients with fatty liver disease, confirming its key role in promoting liver cancer growth.
Credit
polyu
Usage Restrictions
nil
License
Original content